Ontozry 12.5 mg
Ontozry 12.5 mg is a medicine authorised by Swissmedic under authorisation number 68051. The authorisation holder is Angelini Pharma S.p.A., Rom, Zweigniederlassung Zug. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 May 2022 and the authorisation is valid without a time limit. ATC code N03AX25 places the medicine in the group Antiepileptics.
| Authorisation number | 68051 |
|---|---|
| Name | Ontozry 12.5 mg |
| Full name | Ontozry 12.5 mg, Tabletten |
| Authorisation holder | Angelini Pharma S.p.A., Rom, Zweigniederlassung Zug |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX25 |
| First authorisation | 19 May 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ontozry 12.5 mg, Tabletten | B | 19 May 2022 |
| 2 | Ontozry 25 mg, Filmtabletten | B | 19 May 2022 |
| 3 | Ontozry 50 mg, Filmtabletten | B | 19 May 2022 |
| 4 | Ontozry 100 mg, Filmtabletten | B | 19 May 2022 |
| 5 | Ontozry 150 mg, Filmtabletten | B | 19 May 2022 |
| 6 | Ontozry 200 mg, Filmtabletten | B | 19 May 2022 |
| 7 | Ontozry 12.5 mg, Tabletten und Ontozry 25 mg, Filmtabletten | B | 19 May 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 2 | 14 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 3 | 14 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 4 | 28 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 12 | 84 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 5 | 14 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 6 | 28 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 13 | 84 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 7 | 14 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 8 | 28 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 14 | 84 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 9 | 14 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 10 | 28 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 15 | 84 | Tablette(n) | N03AX25 | 01.07.1. | B |
| 11 | 2x 14 | Tablette(n) | N03AX25 | 01.07.1. | B |
Scroll the table sideways
Frequently asked questions
Is Ontozry 12.5 mg authorised in Switzerland?
Yes. Ontozry 12.5 mg is authorised by Swissmedic under authorisation number 68051, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ontozry 12.5 mg have?
Ontozry 12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ontozry 12.5 mg?
The authorisation holder is Angelini Pharma S.p.A., Rom, Zweigniederlassung Zug. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.